image_award_gold_left

100

International
Broker Awards

image_award_gold_right

Biotech ETFs

Invest in biotech ETFs at incredibly low fees. Find out why more than 3 million investors choose us.

Open an account
Smartphone displaying EXDEGIRO app stock chart with buy and sell buttons.

Invest in biotech biotech ETFs with EXDEGIRO

Are you interested in biotech or believe an biotech ETF would be a good fit for your portfolio? Investing in ETFs is an easy way to increase the diversification of your portfolio. On our platform, you'll find a wide selection of biotech ETFs.

Not every biotech ETF is the same. ETFs differ from each other in several factors, such as fund size, price, risk and underlying value. For example, they may track different companies or indices. Also, some may pay dividends and others may not.

These are the most traded biotech ETFs by our clients.

ETF name ISIN
Xtrackers Artificial Intelligence & Big Data UCITS ETF (Acc) IE00BGV5VN51
L&G Artificial Intelligence UCITS ETF (Acc) IE00BK5BCD43
WisdomTree Artificial Intelligence UCITS ETF (Acc) IE00BDVPNG13
Global X Robotics & Artificial Intelligence UCITS ETF USD (Acc) IE00BLCHJB90
ARK Artificial Intelligence & Robotics UCITS ETF (Acc) IE0003A512E4

Based on total number of trades on the EXDEGIRO platform from 01.01.25-31.12.25. Only ETFs with more than 100 transactions are considered. The information on this page is intended for informational purposes only and does not provide any recommendations or financial advice. Some ETFs may (temporarily) not be available on our platform due to regulatory reasons.

Investing in ETFs, accessible to everyone

Exchange-traded funds (ETFs) allow you to quickly build a diversified portfolio. We offer a wide range of ETFs trading on 19 major exchanges. Whether you want to invest in local ETFs or global ETFs, investing opportunities are abundant. For more than 1000 ETFs traded on Tradegate, you only pay a €1 handling fee.

With our low fees and wide trading possibilities, we make investing in ETFs accessible to everyone. See a complete overview of our unprecedented rates here.

Open an account

Selected ETFs

COMMISSION

€0

+

HANDLING

€1

Worldwide

COMMISSION

€2

+

HANDLING

€1

*Fees per trade. Currency, connectivity or external product & spread costs may apply. Find out more on our fees page.

Check out the most traded ETFs

These are the most traded ETFs in 2025 included in our Core Selection based on the total number of trades on our British platform.

Statue of Liberty holding torch and tablet with blue background shape

VANGUARD S&P 500 ETF

IE00B3XXRP09

Historic sailing ship with multiple masts and sails on blue background.

VANGUARD FTSE ALL-WLD UCI

IE00BK5BQT80

Desk globe showing world map placed in front of blue triangle shape

ISHARES CORE MSCI WORLD E

IE00B4L5Y983

Close-up of desk globe showing world map with blue background shape

VANGUARD S&P 500 ETF

IE00BFMXXD54

What is an ETF?

ETFs, also known as trackers, are funds that follow the performance of an index, commodity, bond or composition of products. Unlike some other funds, ETFs are bought and sold on a stock exchange. Would you like to learn more about ETFs? Read our ETF article for all you need to know.

Open an account
Shopping basket icon with geometric shapes inside representing a collection of items

Biotech

Biotech explores and develops complex tasks such as speech and image recognition or natural language processing. Digital devices based on biotech are supposed to act and react as similar to humans as possible.

Biotech is widely used in social media and online communications. It can make human intervention unnecessary. A major advantage of biotech applications is that they can work and make decisions independently. Machine learning plays an important role in this: equipment is programmed to learn from its mistakes and improve its performance independently based on as much data and sensors as possible.

biotech has great benefits and potential. Recognising patterns in image and sound while independently taking action on them can improve efficiency in many areas of work. For example, by recognising images and sounds on the road, a self-driving car might soon be able to move through traffic with fewer and fewer mistakes, and without the need for a driver. biotech attempts to replicate, and even improve upon, the human ability to think. In the case of self-driving cars, the goal of this is to remove the chance for human errors and therefore make the world safer. biotech is also being used in healthcare, the military and aerospace: increasingly complex operations can be performed perfectly and without fatigue.

Stylised stack of books with apple on top representing EXDEGIRO Academy education resources
Smartphone interface icon representing EXDEGIRO app features or navigation menu

Why invest in biotech ETFs?

Investing in biotech is interesting because this field has the potential to expand greatly. Currently, biotech is still in its infancy. With ever-larger data sets and computing power, complex human intelligence will be able to be mimicked more and more closely. Increasingly sophisticated applications will therefore be possible, and intelligent work will be taken over by machines more and more efficiently.

biotech ETFs invest in companies that are involved in biotech in one way or another. In particular, they are technology companies focused on the development and improvement of data systems, sensors to recognise patterns and the application possibilities of biotech. Examples of biotech companies are Nvidia and AMD.

The ETFs also invest in organisations that use a lot of biotech in their products or manufacturing processes, such as technology companies Tesla, Amazon and Google. Other sectors that use a lot of biotech are telecommunications, social media, consumer products, financials, aerospace, automotive and healthcare.

The information on this page is intended for informational purposes only and does not provide any recommendations or financial advice.

More than 100 international awards

We strive to offer the best product by being innovative and staying on top of safety and security. These awards are proof of this hard work and the reason we are the market leader in Europe.

Your investment journey starts here

Open a free account and join over 3 million investors worldwide on our user-friendly platform.

Let’s get you started

Note:
Investing involves risks. You can lose your invested funds. This is not investment advice. Consider your knowledge and experience when making investment decisions.

Investing places your capital at risk. Read our full warning here.

icon_close
Logo

Dear investor,

Our on-boarding for new UK clients is temporarily unavailable. Our apologies for the inconvenience.

Kind regards,

EXDEGIRO

icon_close
Logo

Terms and conditions for the £100 transaction fees offer

If you activate your EXDEGIRO investment account before 1 June 2026, EXDEGIRO will reimburse your transaction fees up to £100. The following conditions apply to this offer:

  • The offer is valid until (including) 31 May 2026.
  • During the offer period, new clients who have activated an account will receive up to £100 in transaction fees reimbursed.
  • The first transaction costs (commission and external handling fees) up to £100 within the timeframe until 30 June 2026 will be reimbursed.
  • Currency handling fees (Auto FX trader) are not eligible to be refunded with this promotion.
  • We will reimburse the transaction costs and external handling fees you have incurred (up to a maximum of £100) to your EXDEGIRO account in early July 2026.
  • This offer is only valid for new clients with a UK EXDEGIRO account.
  • To be eligible for this offer, the new client needs to make a first deposit to validate the account (minimum deposit is £0.01) and activate their EXDEGIRO account.
  • New clients who started their registration before the offer period, but activate their EXDEGIRO account during the offer period, are also eligible for this offer.
  • If an existing account is already linked to the address of the new client, participation is excluded.
  • Each new client can only claim the £100 transaction credit once.
  • The transaction fees and handling costs are converted and reimbursed in GBP even if they were charged in EUR. The amount that will be reimbursed in GBP is calculated based on the currency exchange rate applicable on the day of reimbursement.
  • Dutch law is applicable to this promotion.

Acceptance of offer conditions

By participating in the offer, the client automatically accepts the offer conditions and terms. EXDEGIRO may terminate the campaign prematurely or change the campaign conditions. EXDEGIRO will communicate any changes via the website.

Participation

Participation in the offer is open to all clients who have activated an account at EXDEGIRO on or before 31 May 2026.

icon_close